crsp, edit, ntla, beam are next hype stocks that are going to explode? (genome editing stocks: ex vivo, in vivo, base editing). Especially those that was approved by fda: casgevy(crsp, edit, vertex).
they are extremely undervalued right now so I bought some.
Also related stocks: rxrx, ilmn, regn, vertex.
Your opinion?